InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Stark David Matthew, Directeur Juridique. Insider active across 2 companies, notably Teva Pharmaceutical Industries Ltd. Aggregated, 12 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €676k. Activity tracked since 28 July 2022. The latest transaction was filed on 10 November 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Stark David Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
11,420 股Common StockSEC:0001104659-26-074739:0
8,959 股@ US$0.7597100.0% 占其流量Common StockSEC:0001104659-25-110557:0
53,750 股0Common StockSEC:0001104659-25-046870:0
53,750 股0Common StockSEC:0001104659-24-116977:0
16,491 股@ US$9.930923.0% 占其流量Ordinary SharesSEC:0001209191-23-017161:0
13,931 股Ordinary SharesSEC:0001209191-23-016721:0
18,430 股Ordinary SharesSEC:0001209191-23-014442:0
58,163 股@ US$9.036577.0% 占其流量Ordinary SharesSEC:0001209191-22-043422:0
37,939 股Ordinary SharesSEC:0001209191-22-017063:0
18,430 股Ordinary SharesSEC:0001209191-22-014475:0
12,538 股Ordinary SharesSEC:0001209191-22-008418:0
37,884 股Ordinary SharesSEC:0001209191-21-032254:0
12 条申报中的 12 条
About Stark David Matthew
David Matthew Stark is Executive Vice President and Chief Legal Officer at Teva Pharmaceutical Industries Ltd. He is responsible for overseeing the legal and compliance matters of the company, ensuring that operations adhere to applicable regulations.
